Ribavirin
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Ribavirin contains NLT 98.9% and NMT 101.5% of ribavirin (C₈H₁₂N₄O₅), calculated on the dried basis.
2 IDENTIFICATION
Change to read:
A. ▲Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197K▲ (CN 1-May-2020)
B. Thin-Layer Chromatographic Identification Test 〈201〉
Sample solution: 10 mg/mL
Developing solvent system: Acetonitrile and 0.1 M ammonium chloride (9:2)
Spray reagent: Anisaldehyde, sulfuric acid, glacial acetic acid, and alcohol (5:5:1:90)
Analysis: Proceed as directed in the chapter. Allow the plate to air-dry for 15 min, spray with Spray reagent, heat the plate at 110° for 30 min, and locate the spots on the plate by examining the plate in daylight.
Acceptance criteria: Meets the requirements
3 ASSAY
Procedure
Mobile phase: Adjust water with sulfuric acid to a pH of 2.5 ± 0.1. Pass through a suitable filter of 0.5-µm or finer pore size.
Standard solution: 0.025 mg/mL of USP Ribavirin RS in Mobile phase
Sample solution: 0.025 mg/mL of Ribavirin in Mobile phase
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 207 nm
Column: 7.8-mm × 10-cm; packing L17
Column temperature: 65 ± 0.5°
Flow rate: 1 mL/min
Injection volume: 10 µL
System suitability
Sample: Standard solution
Suitability requirements:
Tailing factor: 0.7–1.5
Relative standard deviation: NMT 0.5%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of ribavirin (C₈H₁₂N₄O₅) in the portion of Ribavirin taken:
Result = (rᵤ / rₛ) × (Cₛ / Cᵤ) × 100
rᵤ = peak response from the Sample solution
rₛ = peak response from the Standard solution
Cₛ = concentration of USP Ribavirin RS in the Standard solution (mg/mL)
Cᵤ = concentration of Ribavirin in the Sample solution (mg/mL)
Acceptance criteria: 98.9%–101.5% on the dried basis
4 IMPURITIES
Residue on Ignition 〈281〉
NMT 0.25%
Organic Impurities
Mobile phase, Standard solution, Chromatographic system, and System suitability: Proceed as directed in the Assay.
Sample stock solution: 0.5 mg/mL of Ribavirin in Mobile phase
Analysis
Sample: Sample stock solution
Calculate the percentage of each peak, other than the solvent peak and the ribavirin peak, in the portion of Ribavirin taken:
Result = (rᵢ / rₜ) × 100
rᵢ = response of the individual peak
rₜ = sum of the responses of all the peaks
Acceptance criteria:
Any individual impurity: NMT 0.25%
Total impurities: NMT 1.0%
5 SPECIFIC TESTS
Optical Rotation, Specific Rotation 〈781S〉
Sample solution: 10 mg/mL
Acceptance criteria: −33.5° to −37.0° (t = 20°)
pH 〈791〉
Sample solution: 20 mg/mL
Analysis: Add 0.2 mL of a saturated potassium chloride solution to 50 mL of Sample solution.
Acceptance criteria: 4.0–6.5
Loss on Drying 〈731〉
Analysis: Dry a sample at 105° for 5 h.
Acceptance criteria: NMT 0.5%
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in tight containers.
USP Reference Standards 〈11〉
USP Ribavirin RS

